PABPC4L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.568800E-01
Normal-vs-Stage2
9.103200E-01
Normal-vs-Stage3
9.952400E-01
Normal-vs-Stage4
6.416400E-01
Stage1-vs-Stage2
8.857000E-01
Stage1-vs-Stage3
8.305600E-01
Stage1-vs-Stage4
3.919000E-01
Stage2-vs-Stage3
8.884600E-01
Stage2-vs-Stage4
3.067000E-01
Stage3-vs-Stage4
5.939400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.681000E-01
Normal-vs-AfricanAmerican
9.158800E-01
Normal-vs-Asian
5.589800E-01
Caucasian-vs-AfricanAmerican
6.490200E-01
Caucasian-vs-Asian
3.692400E-01
AfricanAmerican-vs-Asian
3.708400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.555800E-01
Normal-vs-Female
9.735800E-01
Male-vs-Female
3.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.186200E-01
Normal-vs-Age(41-60Yrs)
8.399600E-01
Normal-vs-Age(61-80Yrs)
8.549200E-01
Normal-vs-Age(81-100Yrs)
6.288600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.969000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.036600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.999200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.760430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.000600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.276600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.207400E-01
Normal-vs-Daily Drinker
4.374400E-01
Normal-vs-Weekly Drinker
8.336600E-01
Normal-vs-Occasional Drinker
9.584200E-01
Normal-vs-Social Drinker
7.679400E-01
Non Drinker-vs-Daily Drinker
7.881400E-01
Non Drinker-vs-Weekly Drinker
4.215000E-01
Non Drinker-vs-Occasional Drinker
3.956400E-01
Non Drinker-vs-Social Drinker
1.684990E-01
Daily Drinker-vs-Weekly Drinker
3.095600E-01
Daily Drinker-vs-Occasional Drinker
3.134200E-01
Daily Drinker-vs-Social Drinker
1.354150E-01
Weekly Drinker-vs-Occasional Drinker
8.465600E-01
Weekly Drinker-vs-Social Drinker
3.843600E-01
Occasional Drinker-vs-Social Drinker
5.076200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.635000E-01
Normal-vs-Grade 2
9.521600E-02
Normal-vs-Grade 3
2.269600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.277610E-01
Grade 1-vs-Grade 3
3.530200E-01
Grade 1-vs-Grade 4
2.635000E-01
Grade 2-vs-Grade 3
7.768800E-01
Grade 2-vs-Grade 4
9.521600E-02
Grade 3-vs-Grade 4
2.269600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.848800E-01
Normal-vs-NonDiabetic
8.286200E-01
Diabetic-vs-NonDiabetic
7.828000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.691800E-01
Normal-vs-NoPancreatitis
9.186800E-01
Pancreatitis-vs-NoPancreatitis
2.508100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.168200E-01
Normal-vs-N1
9.521000E-01
N0-vs-N1
8.247200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.624400E-01
Normal-vs-TP53-NonMutant
6.362600E-01
TP53-Mutant-vs-TP53-NonMutant
8.436400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
